Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61:69–90.PubMedCrossRef 2. Chiba T, Marusawa H,

Seno H, Watanabe N: Mechanism for gastric cancer development learn more by Helicobacter pylori infection. J Gastroenterol Hepatol 2008, 23:1175–1181.PubMedCrossRef 3. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL: Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem 2000, 275:16064–16072.PubMedCrossRef 4. Sohn SH, Lee YC: The genome-wide expression ACP-196 profile of gastric epithelial cells infected by naturally occurring cagA isogenic strains of Helicobacter pylori. Environ Toxicol Pharmacol 2011, 32:382–389.PubMedCrossRef 5. Calvino FM, Parra CT: H. pylori and mitochondrial ABT-737 mouse changes in epithelial cells. The role of oxidative stress. Rev Esp Enferm Dig 2010, 102:41–50. 6. Konturek PC, Konturek SJ, Brzozowski T: Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol 2009, 60:3–21.PubMed 7. Pierzchalski P, Pytko-Polonczyk

J, Jaworek J, Konturek SJ, Gonciarz M: Only live Helicobacter pylori is capable of caspase-3 dependent apoptosis induction in gastric mucosa epithelial cells. J Physiol Pharmacol 2009, 60:119–128.PubMed 8. Matsumoto A, Isomoto H, Nakayama M, Hisatsune J, Nishi Y, Nakashima Y, et al.: Helicobacter pylori VacA reduces the cellular expression of STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL, leading to apoptosis in gastric

epithelial cells. Dig Dis Sci 2011, 56:999–1006.PubMedCrossRef 9. Kusters JG, Van Vliet AH, Kuipers EJ: Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006, 19:449–490.PubMedCrossRef 10. Blaser MJ, Atherton FER JC: Helicobacter pylori persistence: biology and disease. J Clin Invest 2004, 113:321–333.PubMed 11. Mimuro H, Suzuki T, Nagai S, Rieder G, Suzuki M, Nagai T, et al.: Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2007, 2:250–263.PubMedCrossRef 12. Buti L, Spooner E, Van der Veen AG, Rappuoli R, Covacci A, Ploegh HL: Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci USA 2011, 108:9238–9243.PubMedCrossRef 13. Tannaes T, Dekker N, Bukholm G, Bijlsma JJ, Appelmelk BJ: Phase variation in the Helicobacter pylori phospholipase A gene and its role in acid adaptation. Infect Immun 2001, 69:7334–7340.PubMedCrossRef 14. Bukholm G, Tannaes T, Nedenskov P, Esbensen Y, Grav HJ, Hovig T, et al.: Colony variation of Helicobacter pylori: pathogenic potential is correlated to cell wall lipid composition. Scand J Gastroenterol 1997, 32:445–454.PubMedCrossRef 15.